Polar Asset Management Partners Inc.
Position in BMY — Bristol Myers Squibb Co
CIK 1326389
TORONTO, A6
Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$335,751
-$1,677,864 QoQ
Shares Held
5,827
-86.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,799
of 2,506 holders
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2021CallValue
$2,743,400
CallShares
44,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Polar Asset Management Partners Inc. holds $38,832,049 across 4 Drug Manufacturers - General names. BMY ranks #3 (0.9% of the industry book) .
All Filings in BMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,751 | 5,827 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $2,013,615 | 43,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,261,997 | 37,088 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,651,264 | 294,400 | Shares | Sole | 2025-02-25 | |
| 2021-12-31 | $2,743,400 | 44,000 | Call | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||